Mar 28, 2024 4:01 pm EDT Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
Mar 20, 2024 8:00 am EDT Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
Mar 14, 2024 8:00 am EDT Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024
Mar 6, 2024 8:00 am EST Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Feb 29, 2024 8:01 am EST Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission
Feb 29, 2024 8:00 am EST Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement
Dec 11, 2023 4:30 pm EST Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Nov 9, 2023 4:00 pm EST Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update
Oct 26, 2023 8:00 am EDT Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023
Oct 3, 2023 8:00 am EDT Achieve Life Sciences Announces Participation at Upcoming Investor Conferences